SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-18-294717
Filing Date
2018-10-05
Accepted
2018-10-05 16:31:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d634882d424b5.htm 424B5 365580
2 GRAPHIC g634882g97m83.jpg GRAPHIC 16028
  Complete submission text file 0001193125-18-294717.txt   388861
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-226652 | Film No.: 181110864
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1